Company: Boston Children’s Hospital
Job title: Director, Clinical Operations, Gene Therapy Program
Ms. Dansereau is an experienced pediatric hematology oncology registered nurse with an extensive background and expertise in both clinical research and clinical operations, specifically in the area of gene and cellular therapies. She has developed an extensive research infrastructure that supports over 17+ gene therapy clinical trials using in vivo, ex vivo and gene editing strategies at Boston Children’s Hospital. She is responsible for providing leadership for development of operational strategies, planning and readiness for introducing newly FDA approved commercial gene therapies into the clinical setting at Boston Children’s Hospital.
The Keys to a Successful Clinical Trial for Sickle Cell Disease/ β-Thalassemia 11:00 am
Understanding the operational considerations in conducting these trials – a site perspective Optimizing site selection for a successful short- and long-term partnership Understanding the co-morbidities in the sickle cell and thalassemia patients – considerations for study design and treatment planningRead more
day: Day Two